Skip to content

Sleep, Fatigue, and Dexamethosone in Children With Leukemia

Sleep, Fatigue, and Dexamethosone in Childhood Cancer

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00075101
Enrollment
134
Registered
2004-01-05
Start date
2000-09-30
Completion date
2006-09-30
Last updated
2008-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia

Keywords

Drug Adverse Effect, Pediatric Cancer

Brief summary

The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.

Detailed description

Approximately 134 children and adolescents will be enrolled. All children and adolescents will wear a wrist actigraph for two consecutive 5-day study periods. Children and adolescents will have blood drawn 2 times on Day 1 when they are on dexamethosone. Their parents will complete a sleep diary and fatigue questionnaire by telephone on Days 2 and 5 of both study periods.

Interventions

DRUGDexamethosone

10 day study cycle: 5 day observation pre-steroid,5 day observation post-steroid

Sponsors

National Institute of Nursing Research (NINR)
Lead SponsorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

Children and adolescents with Leukemia, both genders

Design outcomes

Primary

MeasureTime frame
Fatigue and sleep quality changes10 days

Secondary

MeasureTime frame
Pharmacogenetics with dextamethasone use5 days
Pharmacokinetics with dextamethasone use5 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026